School of Medicine
Showing 1,701-1,750 of 13,086 Results
-
Robert Chang, MD
Professor of Ophthalmology
On Partial Leave from 06/01/2026 To 07/03/2026Current Research and Scholarly InterestsI'm interested in developing a best in class glaucoma registry, utilizing modern algorithm techniques on imaging, text, and biologic data for precision health predictive analytics in glaucoma diagnosis and treatment, validating new medical devices and technologies, especially portable ones, and working on implementation science
-
Spencer Chang
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Spencer Chang is a board-certified Internal Medicine physician who practices at the Stanford Internal Medicine Clinic in Palo Alto. Dr. Chang earned his MD at Duke University School of Medicine where he was part of the Primary Care Leadership Track. He completed his Internal Medicine Residency training at UCLA in the Primary Care Program. Dr. Chang has interests in medical education, improving access to primary care, community health, and Asian Pacific Islander health disparities. He believes in a holistic approach to patient care, addressing the physical, mental, and emotional well-being of his patients and partnering with them to achieve their health goals.
-
Stephanie Tzu-Ying Chang
Assistant Professor of Radiology
BioDr. Stephanie Chang is an Assistant Professor in Radiology at Stanford University School of Medicine, Section Chief in Abdominal Imaging, and Interim Director of Diagnostic Radiology in the Department of Radiology at VA Palo Alto.
Dr. Chang’s research program aims to utilize state-of-the-art diagnostic technology to non-invasively detect abdominal diseases that predispose or lead to cancer since the most beneficial and cost-effective cancer imaging occurs in the screening/early detection phase.
Currently, metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are leading worldwide causes of end-stage liver disease and liver cancer (hepatocellular carcinoma, HCC). To determine the optimal multimodality screening and diagnostic pathway, Dr. Chang leads prospective research studies at VA Palo Alto comparing blood-based and imaging-based diagnostic tests – the Fibrosis-4 (FIB-4) Index, the Enhanced Liver Fibrosis (ELF) test, vibration controlled transient elastography (VCTE), ultrasound point shear wave elastography (US pSWE), and magnetic resonance imaging (MRI) elastography – among high-risk veterans with obesity and/or type 2 diabetes to compare relative performance and costs/benefits.
To improve detection of hepatocellular carcinoma (HCC) among patients with end-stage liver disease (cirrhosis), Dr. Chang also serves as a member of the VA National Radiology Working Group and radiology local site investigator at VA Palo Alto for a multicenter VA research study CSP #2023 PREventing liver cancer Mortality through Imaging with Ultrasound vs. MRI (PREMIUM STUDY) comparing US and MRI to determine optimal screening strategies for hepatocellular carcinoma.
While MRI has the overall highest sensitivity and specificity for many diseases and contains additional biological/prognostic information not obtainable via other imaging methods, the utility of MRI as a powerful non-invasive screening tool has been hampered by its limitations in access, time, and cost. Dr. Chang is interested in significantly shortening MRI exam times to accelerate MRI throughput, decrease patient discomfort, and reduce costs. To accomplish this goal, Dr. Chang is interested in improving pulse sequences to shorten MRI acquisition times while maintaining or increasing diagnostic quality. In addition, Dr. Chang is interested in novel MRI techniques to improve disease detection and staging. -
Stephen Chang, MD, PhD
Instructor, Biochemistry
Instructor, Medicine - Cardiovascular MedicineBioPrior to a career in medicine, Dr. Chang was an English major and subsequent novelist at night. During the days, he taught literature part-time at Rutgers University, and for extra money, worked in a laboratory in NYC washing test tubes. Inspired by his laboratory mentor, he began volunteering at the hospital next door, and developed a love for interacting with patients. Through this experience, he saw how caring for others could form deep bonds between people - even strangers - and connect us in a way that brings grandeur to ordinary life.
In addition to seeing patients, Dr. Chang is a physician-scientist devoted to advancing the field of cardiovascular medicine. His research has been focused on identifying a new genetic organism that better models human heart disease than the mouse. For this purpose, he has been studying the mouse lemur, the smallest non-human primate, performing cardiovascular phenotyping (vital signs, ECG, echocardiogram) on lemurs both in-bred (in France) and in the wild (in Madagascar) to try to identify mutant cardiac traits that may be heritable - and in the process, characterize the first high-throughput primate model of human cardiac disease. -
Steven D. Chang, MD
Robert C. and Jeannette Powell Neurosciences Professor and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsClinical research includes studies in the treatment of cerebrovascular disorders, such as aneurysms and AVMs, as well as the use of radiosurgery to treat tumors and vascular malformations of the brain and spine.
Dr. Chang is C0-Director of the Cyberknife Radiosurgery Program.
Dr. Chang is also the head of the The Stanford Neuromolecular Innovation Program with the goal of developing new technologies to improve the diagnosis and treatment of patients affected by neurological conditions. -
Tara I. Chang
Stanford University Professor of Nephrology
Current Research and Scholarly InterestsMy research focuses on issues such as blood pressure control, coronary revascularization, and the comparative effectiveness of cardioprotective medications in patients with chronic kidney disease, with the long-term goal of improving cardiovascular outcomes in these high-risk patients.
-
Timothy C. Chang
Clinical Assistant Professor, Urology
BioDr. Timothy Chang is a Clinical Assistant Professor of Urology at Stanford University. He graduated with High Honors from Princeton University and received a Master of Science from Massachusetts Institute of Technology. He then obtained his medical degree and urology residency training from Stanford University School of Medicine. Dr. Chang has experience in a broad range of adult general urologic care, with a particular focus on kidney stone treatment for which he completed specialized fellowship training at Stanford. He received multiple research awards and authored or co-authored numerous academic publications. With his experience in both the engineering and medical fields, he has particular interest in developing technological medical advancements.
-
Lisa Chao, MD, FACOG
Clinical Associate Professor, Obstetrics & Gynecology
BioDr. Lisa Chao is a fellowship-trained, minimally invasive gynecologic surgeon who specializes in complex pelvic surgery for benign gynecologic conditions including endometriosis, pelvic pain, uterine fibroids, abnormal uterine bleeding, adnexal cysts, and other conditions that may require minimally invasive surgery. She is devoted to improving women’s health through evidence-based practice and by providing compassionate, holistic, and patient-centered approach to care. Committed to helping those with endometriosis and pelvic pain, she takes on a multimodal and multidisciplinary approach. Her clinical interests include complex gynecologic surgery, advanced laparoscopic techniques, large fibroids, advanced endometriosis, and pelvic pain. Her academic interests include surgical education and simulation training.
Dr. Chao earned her medical degree at the University of Illinois College of Medicine. She completed a residency in obstetrics and gynecology at Stanford University and received advanced training in minimally invasive gynecologic surgery through a fellowship at the University of Pittsburgh Medical Center’s Magee-Womens Hospital. Prior to returning to Stanford University, she was a member of the faculty at the University of Texas Southwestern Medical Center in Dallas, TX and served as Associate Director of the Minimally Invasive Gynecologic Surgery Fellowship Program where she trained both fellows and residents.
Dr. Chao has authored many peer-reviewed research articles and delivered numerous presentations at international meetings. She is a peer reviewer for the American Journal of Obstetrics and Gynecology and has been a ‘Top Reviewer’ since 2020 for the journal, Obstetrics and Gynecology. She is also an active member of the American Association of Gynecologic Laparoscopists (AAGL), the American College of Obstetricians and Gynecologists (ACOG), and the Society of Gynecologic Surgeons (SGS). She holds leadership positions and serves as an expert on several national committees for these organizations. -
Stephanie D. Chao, MD FACS FAAP
Associate Professor of Surgery (Pediatric Surgery) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsDr. Chao is passionate about disease prevention as she believes it is the ultimate way to impact the health of a population. Surgeons often see the devastating, end-results of the failure of prevention. With this perspective, Dr. Chao believes that it is crucial for surgeons to be active in prevention research. Dr. Chao currently serves as Trauma Medical Director of Lucile Packard Children’s Hospital and focuses much of her research on injury prevention.
-
Steven Z. Chao
Clinical Professor (Affiliated), Adult Neurology
Staff, Adult NeurologyBioDr. Steven Chao graduated from UCLA in biochemistry with highest honors, Summa Cum Laude. He then finished his combined MD/PhD training program from Chicago Medical School/Rosalind Franklin University with AOA Honors. Following his neurology residency at Stanford, he continued with a behavior neurology fellowship training at UCSF Memory and Aging Center, where he started research in dementia.
Currently, He serves as a staff neurologist at the Palo Alto VA and with an appointment at the Stanford Department of Neurology as a clinical professor (affiliated). His current research interest is in early imaging diagnosis of dementia and early treatment/prevention of Alzheimer’s disease, cognitive treatment in traumatic brain injury, and alternative treatments for headache.
Community and academic education about dementia and cognitive health has always been his passion, and he continues to publish research articles and book chapters to support clinical education. -
Danton Char
Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric)
Current Research and Scholarly InterestsDr. Char's research is focused on identifying and addressing ethical concerns associated with the implementation of next generation technologies like whole genome sequencing and its attendant technologies like machine learning to bedside clinical care.
-
Sripriya Chari
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Sripriya (Priya) Chari is a CA Licensed Clinical Psychologist and Clinical Associate Professor working across the INSPIRE, PTSD and centerspace Clinics at Stanford. Dr. Chari's clinical interests lie in early intervention and providing evidence-based treatments for trauma and psychosis, as well as culturally-attuned services to people from the South Asian diaspora. She is involved in teaching undergraduates (IntroSem on Destigmatizing Psychosis) as well as graduate students (Clinical Perspectives on Trauma Psychology), as well as supervising postdoctoral fellows and practicum students. In addition, she leads outreach efforts into the local South Asian community with a view to educating people about mental health.
-
Vivek Charu
Assistant Professor of Pathology and of Medicine (Computational Medicine)
BioI am a physician and a biostatistician. My clinical expertise is in the diagnosis of non-neoplastic kidney and liver disease (including transplantation). My research interests center on the design of observational studies and clinical trials, the analysis of observational data, and causal inference.
-
Greg Charville, MD, PhD
Associate Professor of Pathology
BioDr. Charville has a special interest in the diagnosis of rare tumors that derive from bone and soft tissues, including muscle, fat, blood vessels, cartilage, and other connective tissues. He also specializes in the classification and study of diseases related to the gastrointestinal and hepatopancreatobiliary systems.
Dr. Charville particularly enjoys working alongside Stanford's excellent physicians-in-training to classify the most diagnostically challenging cases in collaboration with pathologists from around the world, bringing to bear cutting-edge techniques for comprehensive histologic and molecular characterization in each case. This experience serves as the inspiration for laboratory-based investigation of the molecular underpinnings of human disease, focusing on genetic and epigenetic mechanisms of neoplasia and the translation of these mechanistic insights into novel diagnostic and predictive biomarkers. -
Amanda Chase
Associate Director of Strategic Research Development, Cardiovascular Institute Operations
Current Role at StanfordAs a Grant Writer and Project Coordinator at the CVI, Dr. Chase:
•Provides grantsmanship support to CVI faculty and postdoctoral fellows
•Edits and critically evaluates grant applications and manuscripts
•Develops communication pieces to promote publications from CVI faculty -
Kushal Chatterjee
Assistant Clinical Research Coordinator, CV Med - Clinical Trials
Current Role at StanfordClinical Research Coordinator at Stanford School of Medicine (Department of Cardiovascular Medicine).
-
Shreyan Chatterjee
Affiliate, Medicine
BioI am currently a rising senior at University High School, Irvine CA and a biomedical engineering aspirant.
I am the Co-founder of Irvine Hope (www.IrvineHope.net ), a non profit organization working globally for creating awareness about climate change and disease challenges.
Me and my twin sister have worked in India, Bangladesh, Myanmar, Malawi and Mozambique for raising awareness about significant health issues and disparities. Here at home, we work with the Advocates for the African American Elders in a federal funded study.
I am an OCSEF First Place winner and California State Finalist (CSEF) for Physiology/Medicine Science (2024 and 2026) and Second Place winner of the IUSD Science Fair competition in 2024 and 2025; First Place in 2026.
I have completed a research internship at University of California, San Diego, Department of Pediatrics (Mentor Dr. Philip Hartmann and Dr. Berndt Schnabl)
I published an article in American Journal of Physiology-Liver and Gastrointestinal Physiology) in 2025. -
Gaurav Mohit Chattree
Instructor, Adult Neurology
BioDr. Chattree is a board-certified neurologist with the Stanford Movement Disorders Center and an Instructor in the Department of Neurology and Neurological Sciences. He provides comprehensive care for patients with movement disorders, which includes deep brain stimulation evaluation/programming and botulinum toxin injections. In addition to his clinical practice, Dr. Chattree conducts research in the lab of Dr. Mark Schnitzer at Stanford, where he uses optical and genetic techniques in mice to develop new treatments for movement disorders.
